EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Application of the American Heart Association/American College of Cardiology/Heart Failure Society of America Heart Failure Staging Guidelines in Adults With Chronic Kidney Disease

Anna M Zemke iD, Leila R Zelnick iD, Joachim H Ix iD, Alan S Go iD, Edward D Siew iD, Nisha Bansal iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.039868 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Anna M Zemke und 5 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Research Institute, Division of Nephrology University of Washington Seattle WA USA. Hauptthemen laut MEDLINE: Heart Failure, Renal Insufficiency, Chronic, Practice Guidelines as Topic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In 2022 the American Heart Association/American College of Cardiology/Heart Failure Society of America Guidelines for Management of Heart Failure proposed an updated staging system with cardiac biomarkers to diagnose heart failure (HF) and its severity. The applicability of this staging system in chronic kidney disease is not well established.

Methods

This is a prospective cohort study of 2415 participants from CRIC (Chronic Renal Insufficiency Cohort). Individuals were classified into HF stages using 2013 and 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America HF guidelines using research echocardiograms, cardiac biomarkers (troponin T ≥10 ng/L [women], ≥15 ng/L [men], pro‐B‐type natriuretic peptide ≥125 pg/mL), laboratory measures, and history. Adjudicated outcomes of HF hospitalizations and all‐cause mortality are reported.

Results

In individuals with chronic kidney disease, participants with lower estimated glomerular filtration rates were more likely to be reclassified to a more advanced HF stage using the current proposed thresholds of hsTNT (high‐sensitivity troponin T) and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide). The 2022 guidelines reclassified 55% of 2013 guideline stage A participants to stage B. HF hospitalization incidence rates differed when individuals were categorized into stage B HF based on elevated hsTNT or NT‐proBNP (1.7 per 100 person‐years) compared with echocardiographic abnormalities (2.9 per 100 person‐years), whereas death rates were similar between these groups.

Conclusions

Among individuals with CKD, the addition of elevated hsTNT or NT‐proBNP to HF staging reclassified nearly 20% of total participants into a higher HF stage. These individuals had similar mortality rates to those previously in higher stages, but they had lower HF hospitalization rates. Those with more advanced chronic kidney disease were more likely to be reclassified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureRenal Insufficiency, ChronicPractice Guidelines as TopicHumansFemaleMaleBiomarkersMiddle AgedProspective StudiesAgedUnited StatesNatriuretic Peptide, BrainTroponin TAmerican Heart AssociationPeptide FragmentsSeverity of Illness IndexGlomerular Filtration RateCardiologyHospitalizationEchocardiography

Stichwörter der Autor:innen

cardiac biomarkerschronic kidney diseaseheart failurehospitalizationsmortality

Substanzen

BiomarkersNatriuretic Peptide, BrainTroponin Tpro-brain natriuretic peptide (1-76)Peptide Fragments

Autor:innen und Institutionen

  • Kidney Research Institute, Division of Nephrology University of Washington Seattle WA USA.
  • Division of Nephrology-Hypertension, Department of Medicine University of California San Diego San Diego CA USA.
  • Veterans Affairs San Diego Healthcare System San Diego CA USA.
  • Division of Research Kaiser Permanente Northern California Pleasanton CA USA.
  • Division of Nephrology and Hypertension, Department of Medicine Vanderbilt University Medical Center Nashville TN USA.
  • Tennessee Valley Health Services Nashville VA Nashville TN USA.

ORCID-Profile: Anna M Zemke, Leila R Zelnick, Joachim H Ix, Alan S Go, Edward D Siew, Nisha Bansal

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Zemke, A. M., Zelnick, L. R., Ix, J. H., Go, A. S., Siew, E. D., & Bansal, N. (2025). Application of the American Heart Association/American College of Cardiology/Heart Failure Society of America Heart Failure Staging Guidelines in Adults With Chronic Kidney Disease. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.039868

Vancouver

Zemke AM, Zelnick LR, Ix JH, Go AS, Siew ED, Bansal N. Application of the American Heart Association/American College of Cardiology/Heart Failure Society of America Heart Failure Staging Guidelines in Adults With Chronic Kidney Disease. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.039868

BibTeX
@article{Zemke2025,
  author = {Zemke, Anna M and Zelnick, Leila R and Ix, Joachim H and Go, Alan S and Siew, Edward D and Bansal, Nisha},
  title = {Application of the American Heart Association/American College of Cardiology/Heart Failure Society of America Heart Failure Staging Guidelines in Adults With Chronic Kidney Disease},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.039868}
}
Kostenlos starten →